ARCHIVES

Leptin Could Be Indicator Of Breast Cancer Risk

This article is from The Cancer Letter archive.

Vol. 26 No. 4 | April 25, 2003

Download PDF Visit The Full Archive

Related Articles

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

Tamoxifen: No Mortality Benefit For Most “High Risk” Women

September 29, 2006

Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages Are Created Equal

December 16, 2011

DCT Board Pediatric Phase 1 Studies, Effort to Assess Obstacles To Clinical Trials

July 6, 1984

HHS Forms Rural Task Force To Study, Improve Programs.

July 27, 2001

Taxol Released On Compassionate Use Basis To Centers; Ohio, Columbia Begin Treatments

October 18, 1991